Understand the source comparison
Quickcomparison
Dose Range Gonadorelin (GnRH) 0.1-1.5–3-10 mg Human Chorionic Gonadotropin (HCG) 250–2000 IU Frequency Once daily Twice weekly Administration Subcutaneous injection Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- Gonadorelin (GnRH)
- 0.1-1.5–3-10 mg
- Human Chorionic Gonadotropin (HCG)
- 250–2000 IU
- Frequency
- Once daily
- Twice weekly
- Administration
- Subcutaneous injection
- Cycle Length
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Strong human trials (Phase 3 or FDA approved)
- Efficacy